Swedbank
NVCR icon

Swedbank’s NovoCure NVCR Stock Holding History

Swedbank’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-87,340
Closed -$3.62M – 720
2023
Q2 		$3.62M Sell
87,340
-1,200
-1% -$74.5K 0.01% 552
2023
Q1 		$5.32M Sell
88,540
-400
-0.4% -$32K 0.01% 502
2022
Q4 		$6.52M Buy
88,940
+100
+0.1% +$7.52K 0.01% 469
2022
Q3 		$6.75M Hold
88,840
– – 0.02% 458
2022
Q2 		$6.17M Buy
88,840
+11,500
+15% +$866K 0.01% 491
2022
Q1 		$6.41M Buy
77,340
+48,900
+172% +$3.6M 0.01% 511
2021
Q4 		$2.27M Buy
28,440
+200
+0.7% +$20.1K ﹤0.01% 630
2021
Q3 		$3.28M Buy
28,240
+5,054
+22% +$764K 0.01% 595
2021
Q2 		$5.14M Buy
+23,186
New +$4.51M 0.01% 549

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Swedbank's NVCR Position: Q3 2023 in Review

Swedbank sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 87,340 shares — an estimated $3.62M sold.

Swedbank first reported a position in NVCR in Q2 2021 and held it in 9 quarters. The position peaked at $6.75M in Q3 2022. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • Swedbank reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
  • Swedbank sold 87,340 NovoCure shares in Q3 2023, an estimated $3.62M.
  • Swedbank first reported a position in NovoCure in Q2 2021 and held it in 9 quarters.
  • Swedbank's NovoCure position peaked at $6.75M in Q3 2022.
  • 226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Swedbank's 13F filing for Q3 2023, filed 6 Dec 2024.